Drug Shortage Report for TEVA-HALOPERIDOL

Last updated on 2019-12-05 History
Report ID 99929
Drug Identification Number 00363650
Brand name TEVA-HALOPERIDOL
Common or Proper name HALOPERIDOL 5MG TABLETS
Company Name TEVA CANADA LIMITED
Active Ingredient(s) HALOPERIDOL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N05AD
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-28
Estimated end date 2020-01-31
Actual end date
Shortage status Actual shortage
Updated date 2019-12-05
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-12-05 French Compare
v4 2019-12-05 English Compare
v3 2019-11-29 English Compare
v2 2019-11-28 French Compare
v1 2019-11-28 English Compare